Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Ming-Ann Hsu"'
Autor:
Laura C. Coates, Andrew G. Bushmakin, Oliver FitzGerald, Dafna D. Gladman, Lara Fallon, Joseph C. Cappelleri, Ming-Ann Hsu, Philip S. Helliwell
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-12 (2021)
Abstract Background In psoriatic arthritis (PsA), further understanding of the relationships between clinical measures and patient-reported outcomes (PROs) is needed. This post hoc analysis evaluated associations between minimal disease activity (MDA
Externí odkaz:
https://doaj.org/article/cd476b3170c24c1ab4878ba4f7f11a0e
Autor:
Peter Nash, Laura C. Coates, Alan J. Kivitz, Philip J. Mease, Dafna D. Gladman, José A. Covarrubias-Cobos, Oliver FitzGerald, Dona Fleishaker, Cunshan Wang, Joseph Wu, Ming-Ann Hsu, Sujatha Menon, Lara Fallon, Ana Belén Romero, Keith S. Kanik
Publikováno v:
Rheumatology and Therapy, Vol 7, Iss 3, Pp 553-580 (2020)
Abstract Introduction Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). We report the interim safety, tolerability, and efficacy of tofacitinib in PsA patients in OPAL Balance, a 3-year, open-label, long-te
Externí odkaz:
https://doaj.org/article/86b13f128d894de4aa055f152d42c856
Autor:
David Cella, Hilary Wilson, Huda Shalhoub, Dennis A. Revicki, Joseph C. Cappelleri, Andrew G. Bushmakin, Elizabeth Kudlacz, Ming-Ann Hsu
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-12 (2019)
Abstract Background To evaluate the measurement properties (e.g., content validity, reliability, and ability to detect change) of the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scale in patients with active psoriatic arthritis (
Externí odkaz:
https://doaj.org/article/abdcbd918ee343578f7765db3576fe7d
Autor:
David Cella, Hilary Wilson, Huda Shalhoub, Dennis A. Revicki, Joseph C. Cappelleri, Andrew G. Bushmakin, Elizabeth Kudlacz, Ming-Ann Hsu
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-11 (2019)
Abstract Background To evaluate the measurement properties (e.g. content validity, reliability and ability to detect change) of the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue scale in patients with active psoriatic arthritis (Ps
Externí odkaz:
https://doaj.org/article/ace51d44f37546f9acbc909afff5c422
Autor:
Iain B McInnes, Kurt de Vlam, Cunshan Wang, Ming-Ann Hsu, Kenneth Kwok, David Gruben, Alexis Ogdie, Philip Baer, Tatjana Lukic, Anna Maniccia
Publikováno v:
RMD Open, Vol 6, Iss 1 (2020)
Objective To describe the efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) or ankylosing spondylitis (AS) in a post-hoc analysis of randomised controlled trials.Methods Data were collected
Externí odkaz:
https://doaj.org/article/d482310d36ba436197cb2bf7a80a9d3c
Autor:
Dafna D. Gladman, MD, Ana-Maria Orbai, MD, Juan Gomez-Reino, MD, Stacey Chang-Douglass, PhD, Emanuele Leoncini, PhD, Hannah E. Burton, MSc, Keith S. Kanik, MD, Ana Belen Romero, MD, Joseph C. Cappelleri, PhD, Ming-Ann Hsu, MPH
Publikováno v:
Current Therapeutic Research, Vol 93, Iss , Pp 100601- (2020)
ABSTRACT: Background: Tofacitinib and other new treatments approved for use in psoriatic arthritis have only recently been included in psoriatic arthritis treatment guidelines, and studies evaluating the relative efficacy of available therapies are i
Externí odkaz:
https://doaj.org/article/c96f546f47fa4449892fb3100240a1d1
Autor:
Philip Helliwell, Laura C. Coates, Oliver FitzGerald, Peter Nash, Enrique R. Soriano, M. Elaine Husni, Ming-Ann Hsu, Keith S. Kanik, Thijs Hendrikx, Joseph Wu, Elizabeth Kudlacz
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-13 (2018)
Abstract Background The multiple disease domains affected in psoriatic arthritis (PsA) may make composite endpoints appropriate for assessing changes in disease activity over time. Tofacitinib is an oral Janus kinase inhibitor for the treatment of Ps
Externí odkaz:
https://doaj.org/article/993f00951db4496f85d699f96eba7244
Autor:
Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Daniela Graham, Cunshan Wang, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu
Publikováno v:
RMD Open, Vol 5, Iss 1 (2019)
Objectives Tofacitinib is an oral Janus kinase inhibitor for treatment of psoriatic arthritis (PsA). We evaluated patient-reported outcomes (PROs) in patients with PsA refractory to ≥1 conventional synthetic disease-modifying antirheumatic drug (cs
Externí odkaz:
https://doaj.org/article/3ce70b78fcd64432b61b5c5d39a99ba1
Autor:
Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu, Linda Chen, Elizabeth Kudlacz, Joseph Wu
Publikováno v:
RMD Open, Vol 5, Iss 1 (2019)
Objectives Tofacitinib is an oral Janus kinase inhibitor for treatment of psoriatic arthritis (PsA). Patient-reported outcomes (PROs) were evaluated in patients with PsA with inadequate responses to tumour necrosis factor inhibitors (TNFi-IR) in a 6-
Externí odkaz:
https://doaj.org/article/b588dc5320de4e5ba0b282bb4ec3da0c
Autor:
David Cella, Hilary Wilson, Huda Shalhoub, Dennis A. Revicki, Joseph C. Cappelleri, Andrew G. Bushmakin, Elizabeth Kudlacz, Ming-Ann Hsu
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 3, Iss 1, Pp 1-1 (2019)
The publisher has retracted this article [1] because the incorrect version of the article was published in error.
Externí odkaz:
https://doaj.org/article/ff267b3a80fb46b4b7dfea8b4517f7bf